Clinical Trial

NeoRad Breast Cancer Study

Study acronym: NeoRad
Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The NEORAD trial tests whether preoperative radiotherapy results in an improved DFS and less radiation induced late effect compared to postoperative radiotherapy in higher risk breast cancer after NACT.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2020-02-06; most recent amendment 2025-05-05.
Status change: Not Yet Recruiting → Recruiting 2024-09-16
Trial Details
NCT Number NCT04261244
Lead Sponsor Bielefeld University
Conditions Breast Cancer
Enrollment 1,826 participants
Start Date 2024-02-01
Primary Completion 2028-03-31 (estimated)
Study Completion 2034-03-31 (estimated)
Updated on ClinicalTrials.gov 2025-05-07